At the third plenary at this year's North American Cystic Fibrosis Conference, we explored what it means to partner in care and how to do it better.
Site Search
More than 4,000 cystic fibrosis researchers and caregivers marked the 25th anniversary of the discovery of the CF gene at the 28th annual North American Cystic Fibrosis Conference (NACFC) in Atlanta. Attendees shared information on the latest in CF research and discussed the remarkable progress in treating the disease since that historic milestone.
In the largest forum of its kind, more than 4,000 doctors, scientists and caregivers from around the world are meeting today in Atlanta for the 28th annual North American Cystic Fibrosis Conference (NACFC).
The recipients of this year's Richard C. Talamo Distinguished Clinical Achievement Award, presented at the 2014 North American Cystic Fibrosis Conference, represent a successful collaboration between researchers and clinicians to bring about a significant advance in CF care and treatment. The award is one of the highest honors given by the Cystic Fibrosis Foundation.
Nine cystic fibrosis care centers were awarded the 2013 - 2014 Cystic Fibrosis Quality Care Award for outstanding service to people with CF and their families at the 28th annual North American Cystic Fibrosis Conference in Atlanta.
At this year's 28th North American Cystic Fibrosis Conference, the CF Foundation's first Mary M. Kontos Care Champion Award was presented to two exemplary nurse coordinators.
As a mother of two children with cystic fibrosis, I am glad to hear that the Cystic Fibrosis Foundation is launching the Infection Research Initiative to address the chronic infections that dramatically impact the lives of people with CF.
The video of the second plenary at this year's North American Cystic Fibrosis Conference was focused on lung transplantation and is now available to watch online. Having had a lung transplant and as one of the people with CF featured in the video, this particular session had a personal meaning for me.
This year, theratyping, the process of matching medications with mutations, enabled more people with cystic fibrosis who have rare mutations to benefit from modulators. In the first plenary at the NACFC, we heard more about how theratyping will be used, as well as other future advances coming in CF treatment.